The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Natural Resources >> CEO Interviews >> June 28, 2013

Interview with the President and CEO: H.B. Fuller Company (FUL)

Owens, James J.
James J. Owens was named President and CEO of H.B. Fuller Company in November 2010, where he is leading the company’s transformation and profitable growth in its targeted markets. He joined H.B. Fuller on Sept. 2, 2008, as Senior Vice President of the Americas region, directing all aspects of the company’s operations in its largest region. Prior to H.B. Fuller, Mr. Owens spent 22 years with National Adhesives, a division of ICI — Imperial Chemical Industries Limited — in a variety of management positions. These included Corporate Vice President and General Manager of the North American adhesives business; Division Vice President and General Manager, Europe; Business Director for the pressure sensitive and laminating adhesives business unit; Marketing Manager; and Technical Services Manager. He also ran the North America adhesives business for Henkel after its acquisition of National Adhesives. Mr. Owens serves on Donaldson Company’s board of directors, and he is also a board member of the Adhesive and Sealant Council, the industry’s premier trade association. He served from 2008 until 2010 as Chairman and from 2006 until 2008 as Treasurer. Mr. Owens holds a bachelor’s degree in chemical engineering from the University of Delaware and a master’s in business administration from The Wharton School, University of Pennsylvania.  Profile
TWST: Can you begin with a brief introduction to H.B. Fuller, including a few highlights from the company’s history and an overview of your current operations?

Mr.

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy